Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M R Taskinen

Showing results (261-270 of 318) with videos related to

Pageof 32
Sort By:
Atherosclerosis|September 17, 1999
Intense physical training decreases circulating antioxidants and endothelium-dependent vasodilatation in vivoR Bergholm, S Mäkimattila, M Valkonen, et al.
Human Genetics|September 1, 1991
Polymorphisms of the gene encoding cholesterol ester transfer protein and serum lipoprotein levels in subjects with and without coronary heart diseaseH Tenkanen, P Koshinen, K Kontula, et al.
Circulation|October 23, 1997
Prevention of the angiographic progression of coronary and vein-graft atherosclerosis by gemfibrozil after coronary bypass surgery in men with low levels of HDL cholesterol. Lopid Coronary Angiography Trial (LOCAT) Study GroupM H Frick, M Syvänne, M S Nieminen, et al.
Atherosclerosis|December 20, 1996
Cholesterol efflux from Fu5AH hepatoma cells induced by plasma of subjects with or without coronary artery disease and non-insulin-dependent diabetes: importance of LpA-I:A-II particles and phospholipid transfer proteinM Syvänne, G Castro, C Dengremont, et al.
Atherosclerosis|August 12, 1998
The 5A/6A polymorphism in the promoter of the stromelysin-1 (MMP-3) gene predicts progression of angiographically determined coronary artery disease in men in the LOCAT gemfibrozil study. Lopid Coronary Angiography TrialS E Humphries, L A Luong, P J Talmud, et al.
Diabetologia|December 22, 2007
USF1 gene variants contribute to metabolic traits in men in a longitudinal 32-year follow-up studyK Auro, K Kristiansson, B Zethelius, et al.
Biochimica Et Biophysica Acta|January 16, 1992
A novel polymorphism of apolipoprotein A-IV is the result of an asparagine to serine substitution at residue 127H Tenkanen, P Koskinen, J Metso, et al.
Diabetologia|June 8, 2010
Ability of traditional lipid ratios and apolipoprotein ratios to predict cardiovascular risk in people with type 2 diabetesM-R Taskinen, P J Barter, C Ehnholm, et al.
Diabetologia|February 14, 2009
Serum saturated fatty acids containing triacylglycerols are better markers of insulin resistance than total serum triacylglycerol concentrationsA Kotronen, V R Velagapudi, L Yetukuri, et al.
European Journal of Clinical Investigation|July 1, 1993
High density lipoprotein subfractions, apolipoprotein A-I containing lipoproteins, lipoprotein (a), and cholesterol ester transfer protein activity in alcoholic women before and after ethanol withdrawalM Välimäki, J Kahri, K Laitinen, et al.
Pageof 32

Showing results (261-270 of 318) with videos related to

Sort By:
Pageof 32
Atherosclerosis|September 17, 1999
Intense physical training decreases circulating antioxidants and endothelium-dependent vasodilatation in vivoR Bergholm, S Mäkimattila, M Valkonen, et al.
Human Genetics|September 1, 1991
Polymorphisms of the gene encoding cholesterol ester transfer protein and serum lipoprotein levels in subjects with and without coronary heart diseaseH Tenkanen, P Koshinen, K Kontula, et al.
Circulation|October 23, 1997
Prevention of the angiographic progression of coronary and vein-graft atherosclerosis by gemfibrozil after coronary bypass surgery in men with low levels of HDL cholesterol. Lopid Coronary Angiography Trial (LOCAT) Study GroupM H Frick, M Syvänne, M S Nieminen, et al.
Atherosclerosis|December 20, 1996
Cholesterol efflux from Fu5AH hepatoma cells induced by plasma of subjects with or without coronary artery disease and non-insulin-dependent diabetes: importance of LpA-I:A-II particles and phospholipid transfer proteinM Syvänne, G Castro, C Dengremont, et al.
Atherosclerosis|August 12, 1998
The 5A/6A polymorphism in the promoter of the stromelysin-1 (MMP-3) gene predicts progression of angiographically determined coronary artery disease in men in the LOCAT gemfibrozil study. Lopid Coronary Angiography TrialS E Humphries, L A Luong, P J Talmud, et al.
Diabetologia|December 22, 2007
USF1 gene variants contribute to metabolic traits in men in a longitudinal 32-year follow-up studyK Auro, K Kristiansson, B Zethelius, et al.
Biochimica Et Biophysica Acta|January 16, 1992
A novel polymorphism of apolipoprotein A-IV is the result of an asparagine to serine substitution at residue 127H Tenkanen, P Koskinen, J Metso, et al.
Diabetologia|June 8, 2010
Ability of traditional lipid ratios and apolipoprotein ratios to predict cardiovascular risk in people with type 2 diabetesM-R Taskinen, P J Barter, C Ehnholm, et al.
Diabetologia|February 14, 2009
Serum saturated fatty acids containing triacylglycerols are better markers of insulin resistance than total serum triacylglycerol concentrationsA Kotronen, V R Velagapudi, L Yetukuri, et al.
European Journal of Clinical Investigation|July 1, 1993
High density lipoprotein subfractions, apolipoprotein A-I containing lipoproteins, lipoprotein (a), and cholesterol ester transfer protein activity in alcoholic women before and after ethanol withdrawalM Välimäki, J Kahri, K Laitinen, et al.
Pageof 32